Caitlin Raymond/LinkedIn
Jan 13, 2026, 16:38
Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
”New post, inspired by a case I saw on service: TTP’s Little-Known Cousin: Understanding TAMOF as a TTP-Like Process.
TAMOF is often mislabeled as DIC or dismissed as “just sepsis.”
But mechanistically, it behaves like a secondary thrombotic microangiopathy — driven by endothelial activation, ultra-large vWF, and insufficient ADAMTS13 in context.
The labs are subtle:
- Low platelets
- High LDH
- ± MAHA
- Relatively preserved coagulation studies
Seeing the pattern matters, because TAMOF may be treatable, including consideration of plasma exchange.”
Read the full post here.
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community